Endometrial Adenocarcinoma in a 27-Year-Old Woman

Background Endometrial adenocarcinoma usually occurs after menopause, but in 2%–14% of cases, it occurs in young patients (less than 40 years of age) who are eager to preserve their fertility. Its treatment includes hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy, and, in so...

Full description

Bibliographic Details
Main Authors: Anis Fadhlaoui, Jamel Ben Hassouna, Mohamed Khrouf, Fethi Zhioua, Anis Chaker
Format: Article
Language:English
Published: SAGE Publishing 2010-01-01
Series:Clinical Medicine Insights: Case Reports
Online Access:https://doi.org/10.4137/CCRep.S5346
id doaj-1417e3461cba4f27ab928f1fa38d9660
record_format Article
spelling doaj-1417e3461cba4f27ab928f1fa38d96602020-11-25T03:19:23ZengSAGE PublishingClinical Medicine Insights: Case Reports1179-54762010-01-01310.4137/CCRep.S5346Endometrial Adenocarcinoma in a 27-Year-Old WomanAnis Fadhlaoui0Jamel Ben Hassouna1Mohamed Khrouf2Fethi Zhioua3Anis Chaker4Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Background Endometrial adenocarcinoma usually occurs after menopause, but in 2%–14% of cases, it occurs in young patients (less than 40 years of age) who are eager to preserve their fertility. Its treatment includes hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy, and, in some cases, radiation therapy. Aim To describe a case of endometrial adenocarcinoma occurring in a young woman and to undertake a literature review of risk factors and therapeutic options proposed for young women wishing to preserve their fertility. Case We report a case of endometrial cancer in a 27-year-old woman treated for resistant menorrhagia and cared for in our department as well as in the Salah Azaiez Institute. Conclusion Endometrial adenocarcinoma rarely occurs in young women. In such cases, other therapeutic options can be proposed: progesterone therapy and LH-RH (Luteinzing-Hormone-Releasing-Hormone) agonists therapy in order to preserve fertility in younger patients.https://doi.org/10.4137/CCRep.S5346
collection DOAJ
language English
format Article
sources DOAJ
author Anis Fadhlaoui
Jamel Ben Hassouna
Mohamed Khrouf
Fethi Zhioua
Anis Chaker
spellingShingle Anis Fadhlaoui
Jamel Ben Hassouna
Mohamed Khrouf
Fethi Zhioua
Anis Chaker
Endometrial Adenocarcinoma in a 27-Year-Old Woman
Clinical Medicine Insights: Case Reports
author_facet Anis Fadhlaoui
Jamel Ben Hassouna
Mohamed Khrouf
Fethi Zhioua
Anis Chaker
author_sort Anis Fadhlaoui
title Endometrial Adenocarcinoma in a 27-Year-Old Woman
title_short Endometrial Adenocarcinoma in a 27-Year-Old Woman
title_full Endometrial Adenocarcinoma in a 27-Year-Old Woman
title_fullStr Endometrial Adenocarcinoma in a 27-Year-Old Woman
title_full_unstemmed Endometrial Adenocarcinoma in a 27-Year-Old Woman
title_sort endometrial adenocarcinoma in a 27-year-old woman
publisher SAGE Publishing
series Clinical Medicine Insights: Case Reports
issn 1179-5476
publishDate 2010-01-01
description Background Endometrial adenocarcinoma usually occurs after menopause, but in 2%–14% of cases, it occurs in young patients (less than 40 years of age) who are eager to preserve their fertility. Its treatment includes hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy, and, in some cases, radiation therapy. Aim To describe a case of endometrial adenocarcinoma occurring in a young woman and to undertake a literature review of risk factors and therapeutic options proposed for young women wishing to preserve their fertility. Case We report a case of endometrial cancer in a 27-year-old woman treated for resistant menorrhagia and cared for in our department as well as in the Salah Azaiez Institute. Conclusion Endometrial adenocarcinoma rarely occurs in young women. In such cases, other therapeutic options can be proposed: progesterone therapy and LH-RH (Luteinzing-Hormone-Releasing-Hormone) agonists therapy in order to preserve fertility in younger patients.
url https://doi.org/10.4137/CCRep.S5346
work_keys_str_mv AT anisfadhlaoui endometrialadenocarcinomaina27yearoldwoman
AT jamelbenhassouna endometrialadenocarcinomaina27yearoldwoman
AT mohamedkhrouf endometrialadenocarcinomaina27yearoldwoman
AT fethizhioua endometrialadenocarcinomaina27yearoldwoman
AT anischaker endometrialadenocarcinomaina27yearoldwoman
_version_ 1724622778936590336